Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.4.3 is now displayed on the page, replacing the prior Revision: v3.4.2. This update concerns revision history metadata and does not alter the study content.SummaryDifference0.0%

- Check51 days agoChange DetectedRemoved the old government funding operating-status notice and the prior Revision: v3.4.1; added Revision: v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, informing users that information may not be up to date and the NIH Clinical Center is open with status updates at opm.gov. The page version indicator was updated to Revision: v3.4.1 and the previous Revision: v3.4.0 was removed.SummaryDifference0.4%

- Check65 days agoChange DetectedGlossary toggle is now visible on the page. The page now displays a 'Last Update Submitted that Met QC Criteria' label, includes a 'No FEAR Act Data' notice, and shows 'Revision: v3.4.0' in the footer.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 removed. This is a minor site update with no changes to trial details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.